Process for the purification of lactams
    31.
    发明授权
    Process for the purification of lactams 失效
    洗涤液的方法

    公开(公告)号:US3476744A

    公开(公告)日:1969-11-04

    申请号:US3476744D

    申请日:1966-06-07

    Applicant: INVENTA AG

    CPC classification number: C07D201/16 B01D9/0036 B01D9/0059 B01D11/0488

    Abstract: Lactams are purified by forming a melt of crude lactam and adding to it sufficiently finely divided solid crude lactam to make a mixture in which the melt forms 50-90% by weight, maintaining the mixture in an adiabatic state and, after melting equilibrium is reached, separating crystals of purified lactam from the mixture. The process is particularly suitable for the purification of lactams having 7-13 ring members. The crude lactam may be subjected to a preliminary treatment with potassium permanganate prior to purification.

    Ammonium Sulphate Production on Industrial Scale

    公开(公告)号:US20230054797A1

    公开(公告)日:2023-02-23

    申请号:US17796631

    申请日:2021-02-04

    Applicant: CAP III B.V.

    Abstract: The invention provides a process for the production of crystalline ammonium sulfate, wherein the process comprises performing a Beckmann rearrangement reaction, neutralizing the Beckmann rearrangement reaction mixture, separating a first aqueous ammonium sulfate phase and an aqueous ε-caprolactam phase, charging the first ammonium sulfate phase to a first evaporative type crystallization section wherein crystalline ammonium sulfate is obtained, discharging from the first evaporative type crystallization section mother liquor enriched in organic components, extracting the aqueous ε-caprolactam phase to obtain an extracted ε-caprolactam phase and a second aqueous ammonium sulfate phase, discharging the mother liquor that is discharged from the first evaporative type crystallization section and/or the second aqueous ammonium sulfate phase to a second evaporative type crystallization section wherein evaporative type crystallization is performed so that a three-phase system occurs. At least a liquid oily phase is recovered from the three-phase system. The invention further provides a plant suitable to carry out the process of the invention, crystalline ammonium sulfate and a liquid oily phase obtained by the process of the invention.

    Production method of N-vinyl-2-pyrrolidone
    39.
    发明授权
    Production method of N-vinyl-2-pyrrolidone 有权
    N-乙烯基-2-吡咯烷酮的制备方法

    公开(公告)号:US09096516B2

    公开(公告)日:2015-08-04

    申请号:US13109450

    申请日:2011-05-17

    CPC classification number: C07D207/267 B01D9/0059 C07D201/16

    Abstract: A method for producing N-vinyl-2-pyrrolidone by crystallization including: controlling a water content in a feed N-vinyl-2-pyrrolidone solution at an inlet of a crystallizer so as to be not lower than 0.7% by weight and not higher than 10% by weight based on the total weight of the N-vinyl-2-pyrrolidone solution; and supplying the feed N-vinyl-2-pyrrolidone solution to a crystallization process.

    Abstract translation: 通过结晶生产N-乙烯基-2-吡咯烷酮的方法包括:将结晶器入口处的进料N-乙烯基-2-吡咯烷酮溶液中的水含量控制在不低于0.7重量%且不高于 基于N-乙烯基-2-吡咯烷酮溶液的总重量的10重量%以上; 并将进料N-乙烯基-2-吡咯烷酮溶液供给至结晶过程。

    Acyl-urea derivatives and uses thereof
    40.
    发明授权
    Acyl-urea derivatives and uses thereof 有权
    酰基脲衍生物及其用途

    公开(公告)号:US08846903B2

    公开(公告)日:2014-09-30

    申请号:US12666703

    申请日:2008-06-25

    CPC classification number: C07C275/50

    Abstract: Novel acyl-urea containing compounds, processes of preparing same, compositions containing same and uses thereof in the treatment of neurological diseases and disorders such as epilepsy, neuropathic pain, bipolar disorder, status epilepticus, chemically-induced convulsions and/or seizure disorders, febrile convulsions conditions, metabolic disturbances and a sustenance withdrawal conditions, are provided. Also provided are uses of these and other acyl-urea containing compounds in the treatment of neurological diseases and disorders.

    Abstract translation: 新型含酰基脲的化合物,其制备方法,含有该组合物的组合物及其用于治疗神经疾病和病症如癫痫,神经性疼痛,双相情感障碍,癫痫持续状态,化学诱发性惊厥和/或发作性疾病,发热 提供抽搐状况,代谢紊乱和维持戒断条件。 还提供了这些和其它含酰基脲的化合物在治疗神经疾病和病症中的用途。

Patent Agency Ranking